These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20719246)

  • 41. Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata.
    Nagai T; Shimizu Y; Shirahata T; Sunazuka T; Kiyohara H; Omura S; Yamada H
    Int Immunopharmacol; 2010 Jun; 10(6):655-61. PubMed ID: 20230917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
    Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L
    Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.
    Bickel M; von Hentig N; Wieters I; Khaykin P; Nisius G; Haberl A; Stephan C; Herrmann E; Doerr HW; Brodt HR; Allwinn R
    Clin Infect Dis; 2011 Jan; 52(1):122-7. PubMed ID: 21148530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Worrall EE; Sudarisman ; Priadi A
    Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
    Hovden AO; Cox RJ; Haaheim LR
    Scand J Immunol; 2005 Jul; 62(1):36-44. PubMed ID: 16092921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model.
    Amorij JP; Westra TA; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2007 Dec; 26(1):67-76. PubMed ID: 18061315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel emulsion adjuvant increases the immunogenic responses and protective efficacy of an inactivated influenza vaccine in BALB/c mice.
    Wang S; Ke CW; Zou LR; Jing Z; Xie GX; Li X
    Intervirology; 2009; 52(5):252-7. PubMed ID: 19622895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
    J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
    Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CTA1: Purified and display onto gram-positive enhancer matrix (GEM) particles as mucosal adjuvant.
    Zhang Y; Yu X; Hou L; Chen J; Li P; Qiao X; Zheng Q; Hou J
    Protein Expr Purif; 2018 Jan; 141():19-24. PubMed ID: 28866467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.
    Weldon WC; Zarnitsyn VG; Esser ES; Taherbhai MT; Koutsonanos DG; Vassilieva EV; Skountzou I; Prausnitz MR; Compans RW
    PLoS One; 2012; 7(7):e41501. PubMed ID: 22848514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    Jee PF; Tiong V; Shu MH; Khoo JJ; Wong WF; Abdul Rahim R; AbuBakar S; Chang LY
    PLoS One; 2017; 12(11):e0187718. PubMed ID: 29108012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.
    Ziegler A; Soldner C; Lienenklaus S; Spanier J; Trittel S; Riese P; Kramps T; Weiss S; Heidenreich R; Jasny E; Guzmán CA; Kallen KJ; Fotin-Mleczek M; Kalinke U
    J Immunol; 2017 Feb; 198(4):1595-1605. PubMed ID: 28077601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.